Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients

doi:10.3748/wjg.v31.i21.105895

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (228)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

112

Figures (1-4)

Tables (1-3)

Sum=216

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Jun 7, 2025 (publication date) through Jun 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 7, 2025; 31(21): 105895
Published online Jun 7, 2025. doi: 10.3748/wjg.v31.i21.105895

Full Size Figure Download Figure

Figure 2 The study design and workflow of radiomics analysis. IFX: Infliximab; CT: Computed tomography; VOI: Volume of interest; LASSO: Least absolute shrinkage and selection operator; ROC: Receiver operating characteristic curves.

Citation: Li X, Song FL, He HF, Zeng SM, Feng ZC, Rong PF. Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients. World J Gastroenterol 2025; 31(21): 105895
URL: https://www.wjgnet.com/1007-9327/full/v31/i21/105895.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i21.105895